Columbia researchers found that exposure to famine early in gestation—but not in the first years of life or late gestation—increased the risk of developing type 2 diabetes decades later.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Losing weight is often the easy part; keeping it off is usually a struggle. In the POWERS study, Columbia researchers are now delving into the reasons why some people succeed and some fail.
Columbia researchers have discovered that a nanomaterial injected into mice shrinks fat at targeted locations, highlighting an unexpected strategy to treat obesity.
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
A study of weight loss methods suggests that gastric bypass surgery is the best strategy for patients with type 2 diabetes and severe obesity, regardless of the severity of a patient’s diabetes.